Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Prostate Cancer

  Free Subscription


13.04.2026

1 Eur Urol
2 Int J Urol
1 J Clin Lab Anal
2 J Urol
1 Magn Reson Med
1 Oncogene
3 Prostate
2 Radiology
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Eur Urol

  1. KADAM A, Misra A, Prakash G
    Re: Chase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al. Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol. In press. ht
    Eur Urol. 2026 Apr 8:S0302-2838(26)02062-2. doi: 10.1016/j.eururo.2026.
    PubMed        


    Int J Urol

  2. TAKAHASHI S
    Editorial Comment to Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low- and Intermediate-Risk Localized Prostate Cancer.
    Int J Urol. 2026;33:e70457.
    PubMed        

  3. HONDA K, Oka S, Makiyama K, Tatenuma T, et al
    Artificial Intelligence-Based Recognition of the Prostatic Capsule During Nerve-Sparing Robot-Assisted Radical Prostatectomy.
    Int J Urol. 2026;33:e70454.
    PubMed         Abstract available


    J Clin Lab Anal

  4. KAYALI Y
    Integrating Prostate-Specific Antigen Density and Prostate Imaging Reporting and Data System Scores to Optimize Detection of Clinically Significant Prostate Cancer: A Multivariable Risk Model Approach.
    J Clin Lab Anal. 2026 Apr 4:e70218. doi: 10.1002/jcla.70218.
    PubMed         Abstract available


    J Urol

  5. KOKOROWSKI P, Friedrich NA, Luu M, Shiang A, et al
    Patient Participation in Consultations for Clinically Localized Prostate Cancer: Erratum.
    J Urol. 2026;215:652.
    PubMed        

  6. FENG Y, Zhou S, Huang S, Yu Z, et al
    Letter: The Blind Spot of Prostate-Specific Membrane Antigen Positron Emission Tomography Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomo
    J Urol. 2026;215:653.
    PubMed        


    Magn Reson Med

  7. GHOUL A, Liang C, Loster I, Umapathy L, et al
    Automated Coregistered Segmentation for Volumetric Analysis of Multiparametric Renal MRI.
    Magn Reson Med. 2026;95:3519-3535.
    PubMed         Abstract available


    Oncogene

  8. SUN G, Chen S, Chen M, Xiao X, et al
    NSUN2/ALYREF-mediated RNA m5c modification promotes anoikis resistance of prostate cancer through activating autophagy.
    Oncogene. 2026 Apr 7. doi: 10.1038/s41388-026-03762.
    PubMed         Abstract available


    Prostate

  9. JONNATAN S, Cavka L, De Marzo AM, Denmeade SR, et al
    Castration Resistance Accelerates Prostate Cancer Kinetics.
    Prostate. 2026 Apr 8. doi: 10.1002/pros.70177.
    PubMed         Abstract available

  10. GURBUZ AF, Araz M, Demir H, Guzel HG, et al
    Bone Metastasis Distribution Matters: Prognostic Effect of the Axial-to-Peripheral Ratio in Metastatic Hormone-Sensitive Prostate Cancer.
    Prostate. 2026 Apr 8. doi: 10.1002/pros.70176.
    PubMed         Abstract available

  11. DEIVASIGAMANI S, Kotamarti S, Mottaghi M, Adams ES, et al
    Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.
    Prostate. 2026 Apr 8. doi: 10.1002/pros.70175.
    PubMed         Abstract available


    Radiology

  12. FUTELA D, Yin Z, Mirak SA, Ryan S, et al
    Characterization of Clinically Significant Prostate Cancer in the Peripheral Zone Using Rapid B(1)-Insensitive MR Fingerprinting.
    Radiology. 2026;319:e252547.
    PubMed         Abstract available

  13. MARGOLIS DJA, Gulani V
    A Step Closer to the Promise of Quantitative MRI for Prostate Cancer.
    Radiology. 2026;319:e260545.
    PubMed        


    Urology

  14. ASHBROOK C, Troia TC, Woldu SL, Argenbright K, et al
    Primary Care Physician-Led Population-Based Screening Program for Prostate Cancer: Bridging a Urologic Gap in Access to Care.
    Urology. 2026 Apr 3:S0090-4295(26)00230-X. doi: 10.1016/j.urology.2026.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum